Clostridium Novyi, 8296;Clostridium Perfringens Type C, Pc8
158 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
158
Total Reports
124
Deaths Reported
7850.0%
Death Rate
Active Ingredients
Clostridium Novyi, 8296;Clostridium Perfringens Type C, Pc8
Administration Routes
SubcutaneousUnknownIntramuscular
Species Affected
Cattle 158
Most Affected Breeds
Mixed (Cattle) 108
Aberdeen Angus 19
Holstein-Friesian also known as Holstein 8
Cattle (other) 6
Brangus 4
Red Angus 3
Jersey 3
Simmental 2
Crossbred Bovine/Cattle 2
Texas Longhorn 1
Most Reported Reactions
Death 100
Lack of efficacy - NOS 50
Anaphylactic-type reaction 19
Anaphylaxis 16
Anaphylactoid reaction 10
Unexplained death 8
Lack of efficacy (bacteria) - NOS 8
Injection site swelling 7
Sudden death 7
Injection site abscess 7
Found dead 6
Death by euthanasia 6
Outcome Breakdown
Died
121 (55.3%)
Outcome Unknown
61 (27.9%)
Recovered/Normal
19 (8.7%)
Ongoing
10 (4.6%)
Euthanized
5 (2.3%)
Recovered with Sequela
3 (1.4%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.